These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29135572)

  • 1. Long-term observational studies of chronic granulomatous disease.
    Kanariou M; Spanou K; Tantou S
    Curr Opin Hematol; 2018 Jan; 25(1):7-12. PubMed ID: 29135572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
    Chiriaco M; Salfa I; Di Matteo G; Rossi P; Finocchi A
    Pediatr Allergy Immunol; 2016 May; 27(3):242-53. PubMed ID: 26680691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A therapeutic approach towards chronic granulomatous disease].
    Kawai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):437-46. PubMed ID: 25748127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.
    Åhlin A; Fugeläng J; de Boer M; Ringden O; Fasth A; Winiarski J
    Acta Paediatr; 2013 Nov; 102(11):1087-94. PubMed ID: 23937637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the diagnosis and treatment of chronic granulomatous disease.
    Seger RA
    Curr Opin Hematol; 2011 Jan; 18(1):36-41. PubMed ID: 21076296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients.
    Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Berger-Achituv S; Stauber T; Ben Ari J; Rottem M; Schlesinger Y; Grisaru-Soen G; Abuzaitoun O; Marcus N; Zion Garty B; Broides A; Levy J; Stepansky P; Etzioni A; Somech R; Roos D
    Am J Hematol; 2017 Jan; 92(1):28-36. PubMed ID: 27701760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers.
    Tsilifis C; Torppa T; Williams EJ; Albert MH; Hauck F; Soncini E; Kang E; Malech H; Schuetz C; von Bernuth H; Slatter MA; Gennery AR
    J Clin Immunol; 2023 Nov; 43(8):1964-1973. PubMed ID: 37620741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary manifestations of chronic granulomatous disease.
    Mahdaviani SA; Mohajerani SA; Rezaei N; Casanova JL; Mansouri SD; Velayati AA
    Expert Rev Clin Immunol; 2013 Feb; 9(2):153-60. PubMed ID: 23390946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory manifestations in chronic granulomatous disease (CGD).
    Rosenzweig SD
    J Clin Immunol; 2008 May; 28 Suppl 1():S67-72. PubMed ID: 18193341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSCT in two brothers with CGD arising from mutations in CYBC1 corrects the defect in neutrophil function.
    Perez-Heras I; Tsilifis C; Slatter MA; Brynjólfsson SF; Haraldsson Á; Gennery AR
    Clin Immunol; 2021 Aug; 229():108799. PubMed ID: 34280579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
    Connelly JA; Marsh R; Parikh S; Talano JA
    J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S31-S39. PubMed ID: 29746680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in chronic granulomatous disease.
    Goldblatt D
    J Infect; 2014 Nov; 69 Suppl 1():S32-5. PubMed ID: 25264161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extended understanding of chronic granulomatous disease.
    Lacerda-Pontes R; Gomes LN; Albuquerque RS; Soeiro-Pereira PV; Condino-Neto A
    Curr Opin Pediatr; 2019 Dec; 31(6):869-873. PubMed ID: 31693599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for chronic granulomatous disease.
    Goebel WS; Dinauer MC
    Acta Haematol; 2003; 110(2-3):86-92. PubMed ID: 14583668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Chronic Granulomatous Disease.
    Arnold DE; Heimall JR
    Adv Ther; 2017 Dec; 34(12):2543-2557. PubMed ID: 29168144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic granulomatous disease.
    Roos D
    Br Med Bull; 2016 Jun; 118(1):50-63. PubMed ID: 26983962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulomatous disease - conventional treatment vs. hematopoietic stem cell transplantation: an update.
    Åhlin A; Fasth A
    Curr Opin Hematol; 2015 Jan; 22(1):41-5. PubMed ID: 25394312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease.
    Gabrion A; Hmitou I; Moshous D; Neven B; Lefèvre-Utile A; Diana JS; Suarez F; Picard C; Blanche S; Fischer A; Cavazzana M; Touzot F
    J Allergy Clin Immunol; 2017 May; 139(5):1641-1649.e6. PubMed ID: 27702670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic granulomatous disease: recent advances in pathophysiology and treatment.
    Seger RA
    Neth J Med; 2010 Nov; 68(11):334-40. PubMed ID: 21116026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.